March 7, 2011

The board of directors of Genzyme unanimously recommended that shareholders accept French drug maker Sanofi-Aventis’ $74-per-share buyout offer, Genzyme said Monday.

February 11, 2011

Genentech, a subsidiary of Roche, reported that its eye drug helped improve vision in patients suffering from a complication caused by diabetes.

February 4, 2011

A drug used to treat inflammatory diseases improved the conditions of patients with psoriasis that affected the scalp compared with placebo, according to results of a new study.

January 19, 2011

Drug maker Genentech is hoping to keep a breast cancer treatment on the market as the Food and Drug Administration considers whether to revoke its approval for the disease, according to published reports.

January 18, 2011

Generic drug maker Sandoz has started a mid-stage clinical trial of a monoclonal antibody used to treat cancer and autoimmune disease, the company said.

January 10, 2011

It appears that French drug maker Sanofi-Aventis’ efforts to acquire U.S. biotech company Genzyme are getting somewhere, according to company and media reports.

January 7, 2011

Pfizer has paid Seattle Genetics $8 million to license its antibody technology, Seattle Genetics said Thursday.

January 6, 2011

The Food and Drug Administration has expanded the approved usage of a drug made by Genentech, part of Swiss drug maker Roche.

January 6, 2011

A U.S. biotech company plans to develop a biosimilar of a monoclonal antibody used to treat cancers and autoimmune disorders.

December 21, 2010

An Anglo-Swedish drug maker said it is discontinuing further development of a drug that is designed to prevent a respiratory virus that infects the lungs and breathing passages.

December 16, 2010

Just a few months after a Food and Drug Administration advisory committee recommended limiting the use of a Genentech drug designed to treat breast cancer, the regulatory agency is looking to revoke the approval altogether.

December 7, 2010

The Food and Drug Administration has accepted for review a supplemental approval application for an arthritis drug made by Bristol-Myers Squibb, the drug maker said Monday.

December 6, 2010

A biotech drug made by Roche subsidiary Genentech allowed patients with a blood cancer, who did not show symptoms, to delay starting on chemotherapy or radiotherapy, and decreased the risk of their disease worsening, according to results of a late-stage clinical trial.

November 18, 2010

The Food and Drug Administration has approved a treatment for preventing skeletal injuries in patients...

November 16, 2010

A decision by a Food and Drug Administration advisory committee could pave the way for...

November 7, 2010

Patients with rheumatoid arthritis derive about as much benefit from a weekly injection of a...

November 4, 2010

Biotech company Amgen took home a top award for one of its drugs at an...

November 3, 2010

Swiss drug maker Biogen Idec and U.S. drug maker Cardiokine have terminated an agreement to...

October 20, 2010

The Food and Drug Administration has approved a biotech drug for treating cancer of the...

October 5, 2010

An investigative biotech drug administered together with chemotherapy helped extend the lives of cancer patients...

October 4, 2010

The drug market for ulcerative colitis treatments will see modest growth through 2019, according to...

September 29, 2010

The biotech division of Johnson & Johnson is hoping to expand the use of a...

September 28, 2010

The drug market for Crohn's disease treatments will see moderate growth over the next decade,...

September 28, 2010

While biosimilars promise to provide therapies for a wide range of diseases, their biggest fans...